Cody v. Toller Drug Co.

5 N.W.2d 824, 232 Iowa 475
CourtSupreme Court of Iowa
DecidedOctober 20, 1942
DocketNo. 46116.
StatusPublished
Cited by14 cases

This text of 5 N.W.2d 824 (Cody v. Toller Drug Co.) is published on Counsel Stack Legal Research, covering Supreme Court of Iowa primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Cody v. Toller Drug Co., 5 N.W.2d 824, 232 Iowa 475 (iowa 1942).

Opinion

Garfield, J.

On June 25, 1939, appellee, then a railroad yardmaster, consulted Dr. Sibley, who gave him a written prescription for a tonic in capsule form to be taken internally four times a day. Appellee took the prescription to appellant’s drug store to be filled. He claims appellant negligently included in the capsules “atropine, a poisonous and injurious drug not called for in said prescription.” Appellant maintains the prescription was correctly filled. Upon this appeal, appellant’s principal contention is that the evidence is insufficient to show the capsules contained atropine.

Appellee took a capsule after the noon meal and another in the evening on the 25th. His wife then noticed that his eyes were dilated. He also took a capsule the next morning and another at noon. When eating his noon meal on the 26th, appellee choked on a piece of meat and had to leave the table. He could not swallow. He could not see. That afternoon he was unable to read the numbers on freight cars and could not distinguish people. He began to stagger; his throat was dry and he could hardly talk.

Becoming alarmed, appellee consulted Dr. Sibley in the afternoon of the 26th and told, him he thought something was wrong with the medicine. Dr. Sibley looked appellee .over, and his son, also a physician, examined him. Dr. Sibley phoned appellant’s store and asked a clerk to read the prescription to him to make sure there had been no mistake in writing it. The doctor then told appellee not to take more of the capsules and *477 gave bim a prescription of bromides to settle bis nerves. Dr. Sibley also saw appellee on tbe 27 th, when be called in Dr. Tripp, an eye-and-ear specialist, to observe appellee. Dr. Sibley testified that tbe symptoms be found all pointed to atropine and that the drugs which bad been prescribed could not have caused appellee’s condition; that be bad used this prescription for twenty years and it bad also been used by a former partner.

Dr. Edward Sibley, the son, testified that appellee “certainly seemed to have an acute case of poisoning from something and at that time tbe only thing I could think of that could give such a picture clinically was atropine, or something very closely related to it.” He also said there was no probability that the prescribed drugs would produce the condition in which appellee was found.

Dr. Tripp, who examined appellee’s eyes on the 27th, testified he was familiar with the effect of atropine on the eyes and that appellee’s eyes looked as if they had atropine in them. He also said it was unreasonable that anything contained in Dr. Sibley’s prescription would produce appellee’s widely dilated pupils.

Dr. Krigsten had been appellee’s physician at least part of the time for seven or eight years. After seeing Dr. Sibley, appellee consulted Dr. Krigsten on the 27th. He examined ap-pellee and found him highly nervous, pupils dilated; complained of extreme dryness of throat, his voiee hoarse and husky; and suffering from dizziness. Dr. Krigsten saw appellee every third to sixth day for the remainder of the summer. He testified that appellee was probably suffering from atropine poisoning and that his symptoms could probably not be caused by the medicine 'which Dr. Sibley prescribed.

Dr. Watkin testified, in response to a long hypothetical question, that the symptoms shown by appellee were probably not due to any of the prescribed drugs, specifically or in combination.

Both appellee and his wife testified that appellee had not previously suffered from similar symptoms.

Appellant’s pharmacist, Johnson, who filled the prescription, testified they.had on hand at the time atropine- dispensing *478 tablets which were used “more or less” in prescriptions; that druggists now use such tablets rather than old-fashioned powders in filling prescriptions. He also testified that arsenic and strychnine and atropine, if they had atropine, would be kept together in different bottles in the same compartment, although this was denied by Mr. Toller and Mr. Bogan. Arsenic acid and strychnine sulphate are two of the five drugs prescribed by Dr. Sibley as ingredients of the tablets'. At the time in question Johnson was acting as relief pharmacist in the store because Bogan, chief pharmacist and manager, was on vacation. There is also testimony that the bottles and tablets of these three last-named poisonous drugs were similar in size and shape.

Professor Coss, head of the Momingside College chemistry department, testified that he made a chemical analysis of some of the capsules; that Vitali’s test was positive for atropine or the atropine group; that there was atropine in the capsules, “even more atropine than you would expect.” This witness also performed a biological test by putting a solution from the capsules in one of his eyes. The solution dilated the pupil and indicated the capsules contained atropine or compounds of the atropine group. The professor also said the tests made by him were reliable and approved.

Dean Teeters of the Pharmacy College of Iowa University,a witness for appellant, denied much of Professor Coss’s testimony. He testified that he performed Vitali’s test (which he said was the best for atropine) upon the contents of three of the capsules and found no atropine. Dean Teeters also said it was impossible “to make a chemical examination that would be absolutely trustworthy” of the combination of prescribed drugs.

Upon cross-examination of Professor Coss it was brought out that hyoscyamine and hyoscine, with atropine, are related drugs of ‘ ‘ the atropine group ’ ’ and that he could not be positive from his tests that the capsules contained atropine rather than hyoscyamine or hyoscine; that these three drugs of the atropine group have the same properties and would have the same effect, although they are separate drugs. This testimony furnishes the principal basis for appellant’s claim that appellee failed to prove the capsules contained atropine.

That this argument is somewhat technical is disclosed *479 by the fact that the chemical formula for hyoscyamine is identical with that for atropine, ■ according to the United States Pharmacopoeia, of which we take judicial notice.

I. We think there was sufficient evidence that the capsules contained atropine. Appellee’s medical witnesses testified that appellee, who had taken four of the capsules, showed the characteristic symptoms of atropine poisoning. The jury could have found that, owing to the appearance and location in the prescription counter of the tablets and bottles containing arsenic and strychnine, which were prescribed, and those containing atropine, the latter may have been included. There was no evidence that appellant kept on hand any hyoscyamine or hyoscine, the other two drugs of the atropine group to which witness Coss referred, nor that the capsules in fact contained either drug, but only Coss’s admission that either would produce similar results in Yitali’s test. Dean Teeters, appellant’s expert, did not claim that either of these other two drugs of the atropine group was present in the capsules.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Wolbers v. the Finley Hosp.
673 N.W.2d 728 (Supreme Court of Iowa, 2003)
Millis v. Hute
587 N.W.2d 625 (Court of Appeals of Iowa, 1998)
Martin v. Schoonover
533 P.2d 438 (Court of Appeals of Washington, 1975)
Jones v. Iowa State Highway Commission Ex Rel. State
157 N.W.2d 86 (Supreme Court of Iowa, 1968)
Thomsen v. Rexall Drug & Chemical Co.
235 Cal. App. 2d 775 (California Court of Appeal, 1965)
Bostian v. Jewell
121 N.W.2d 141 (Supreme Court of Iowa, 1963)
State Ex Rel. Rich v. Bair
365 P.2d 216 (Idaho Supreme Court, 1961)
Scanlan v. Scanlan
67 N.W.2d 5 (Supreme Court of Iowa, 1954)
In Re Soanlan's Estate
67 N.W.2d 5 (Supreme Court of Iowa, 1954)
Ipsen v. Ruess
35 N.W.2d 82 (Supreme Court of Iowa, 1948)
McCollough v. Lee
235 Iowa 753 (Supreme Court of Iowa, 1944)
In Re Estate of Hollis
16 N.W.2d 599 (Supreme Court of Iowa, 1944)
Smith v. Pine
12 N.W.2d 236 (Supreme Court of Iowa, 1943)
Craft v. Myers
10 N.W.2d 94 (Supreme Court of Iowa, 1943)

Cite This Page — Counsel Stack

Bluebook (online)
5 N.W.2d 824, 232 Iowa 475, Counsel Stack Legal Research, https://law.counselstack.com/opinion/cody-v-toller-drug-co-iowa-1942.